EUVIMEDEUVIMED entdecken
Crossref

Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis

Kiryu Yoshida iD, Tomohiro Saito, Tadashi Kato, Toshiaki Takezaki, Noriyuki Kato, Masahide Mizobuchi iD, Hiroaki Ogata iD, Fumihiko Koiwa iD, Hirokazu Honda

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1111/1744-9987.70004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Kiryu Yoshida und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, Cardiovascular Diseases, Chelating Agents, Phosphates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phosphate binders (PBs) are commonly prescribed to reduce serum phosphate levels. This study examined the association between the PB pill burden and cardiovascular events in hemodialysis patients.

Methods

This retrospective cohort study included 395 patients undergoing hemodialysis between August 2018 and November 2023 at a single facility in Japan. Statistical analyses were conducted using baseline, time‐averaged, and time‐dependent Cox proportional hazard models.

Results

Of the 395 included patients, cardiovascular events occurred in 121 patients (30.6%). The patients were categorized into tertiles based on their daily PB pill intake: T1 (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCardiovascular DiseasesChelating AgentsPhosphatesHyperphosphatemiaKidney Failure, ChronicHumansMaleFemaleRetrospective StudiesAgedMiddle AgedJapanProportional Hazards Models

Stichwörter der Autor:innen

cardiovascular eventshemodialysisphosphate binderspill burden

Substanzen

Chelating AgentsPhosphates

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Saiyu Clinic, Saitama, Japan.
  • Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Department of Medical Education, Showa University School of Medicine, Tokyo, Japan.

ORCID-Profile: Kiryu Yoshida, Masahide Mizobuchi, Hiroaki Ogata, Fumihiko Koiwa

Zitieren

APA

Yoshida, K., Saito, T., Kato, T., Takezaki, T., Kato, N., Mizobuchi, M., Ogata, H., Koiwa, F., & Honda, H. (2025). Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.70004

Vancouver

Yoshida K, Saito T, Kato T, Takezaki T, Kato N, Mizobuchi M, et al. Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.70004

BibTeX
@article{Yoshida2025,
  author = {Yoshida, Kiryu and Saito, Tomohiro and Kato, Tadashi and Takezaki, Toshiaki and Kato, Noriyuki and Mizobuchi, Masahide and Ogata, Hiroaki and Koiwa, Fumihiko and Honda, Hirokazu},
  title = {Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1111/1744-9987.70004}
}
Kostenlos starten →